US 7815942
Rasagiline formulations of improved content uniformity
granted A61KA61K31/205A61K9/14
Quick answer
US patent 7815942 (Rasagiline formulations of improved content uniformity) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEVA PHARMACEUTICAL INDUSTRIES, LTD.
- Grant date
- Tue Oct 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 37
- CPC classes
- A61K, A61K31/205, A61K9/14, A61K9/2018, A61K9/2059